Linezolid treatment of ventriculoperitoneal shunt infection without implant removal

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 24, Issue 9, 2005, Pages 603-606

  Castro, P ^a   Soriano, A ^a   Escrich, C ^b   Villalba, G ^a   Sarasa, M ^a   Mensa, J ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL VERGE DE LA CINTA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFOTAXIME; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; GENTAMICIN; LINEZOLID; METICILLIN; RIFAMPICIN; VANCOMYCIN;

ADULT; ARTICLE; BACTERIAL INFECTION; BRAIN VENTRICLE PERITONEUM SHUNT; CLINICAL ARTICLE; ENTEROCOCCUS; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RISK FACTOR; SHUNT INFECTION;

ACETAMIDES; ANTI-BACTERIAL AGENTS; DEVICE REMOVAL; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; OXAZOLIDINONES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; VENTRICULOPERITONEAL SHUNT;

EID: 26844544349     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-005-0015-9     Document Type: Article

References (21)

1. Borgbjerg BM, Gjerris F, Albeck MJ, Borgesen SE (1995) Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts. Acta Neurochir (Wien) 136:1-7
2. McGirt MJ, Zaas A, Fuchs HE, George TM, Kaye K, Sexton DJ (2003) Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis 36:858-862
3. George R, Leibrock L, Epstein M (1979) Long-term analysis of cerebrospinal fluid shunt infections. A 25-year experience. J Neurosurg 51:804-811
4. Bayston R (1994) Hydrocephalus shunt infections. J Antimicrob Chemother 34 (Suppl A):75-84
5. James HE, Walsh JW, Wilson HD, Connor JD (1981) The management of cerebrospinal fluid shunt infections: a clinical experience. Acta Neurochir (Wien ) 59:157-166
6. Walters BC, Hoffman HJ, Hendrick EB, Humphreys RP (1984) Cerebrospinal fluid shunt infection. Influences on initial management and subsequent outcome. J Neurosurg 60:1014-1021
7. Bayston R, Ashraf W, Bhundia C (2004) Mode of action of an antimicrobial biomaterial for use in hydrocephalus shunts. J Antimicrob Chemother 53:778-782
8. Pople IK, Bayston R, Hayward RD (1992) Infection of cerebrospinal fluid shunts in infants: a study of etiological factors. J Neurosurg 77:29-36
9. Morissette I, Gourdeau M, Francoeur J (1993) CSF shunt infections: a fifteen-year experience with emphasis on management and outcome. Can J Neurol Sci 20:118-122
10. Viale P, Pagani L, Cristini F, Stefini R, Bergomi R, Colombini P, Carosi G (2002) Linezolid for the treatment of central nervous system infections in neurosurgical patients. Scand J Infect Dis 34:456-459
11. Guevara JA, Zuccaro G, Trevisan A, Denoya CD (1987) Bacterial adhesion to cerebrospinal fluid shunts. J Neurosurg 67:438-445
12. Darouiche RO, Dhir A, Miller AJ, Landon GC, Raad II, Musher DM (1994) Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria. J Infect Dis 170:720-723
13. Pfausler B, Spiss H, Beer R, Kampl A, Engelhardt K, Schober M, Schmutzhard E (2003) Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy. J Neurosurg 98:1040-1044
14. Klibanov OM, Filicko JE, DeSimone JA Jr, Tice DS (2003) Sensorineural hearing loss associated with intrathecal vancomycin. Ann Pharmacother 37:61-65
15. Zeana C, Kubin CJ, la-Latta P, Hammer SM (2001) Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature. Clin Infect Dis 33:477-482
16. Krueger WA, Kottler B, Will BE, Heininger A, Guggenberger H, Unertl KE (2004) Treatment of meningitis due to methicillin-resistant Staphylococcus epidermidis with linezolid. J Clin Microbiol 42:929-932
17. Gill CJ, Murphy MA, Hamer DH (2002) Treatment of Staphylococcus epidermidis ventriculo-peritoneal shunt infection with linezolid. J Infect 45:129-132
18. Graham PL, Ampofo K, Saiman L (2002) Linezolid treatment of vancomycin-resistant Enterococcus faecium ventriculitis. Pediatr Infect Dis J 21:798-800
19. Hachem R, Afif C, Gokaslan Z, Raad I (2001) Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid. Eur J Clin Microbiol Infect Dis 20:432-434
20. Gander S, Hayward K, Finch R (2002) An investigation of the antimicrobial effects of linezolid on bacterial biofilms utilizing an in vitro pharmacokinetic model. J Antimicrob Chemother 49:301-308
21. Bassetti M, Di Biagio A, Cenderello G, Del Bono V, Palermo A, Cruciani M, Bassetti D (2001) Linezolid treatment of prosthetic hip infections due to methicillin-resistant Staphylococcus aureus (MRSA). J Infect 43:148-149